Stanley Frankel

DTIL

Stanley Frankel serves as Director at Precision BioSciences, Inc. (DTIL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$26.1K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$26.1K

Companies Traded

DTIL

Active Period

Sep 2025 – Dec 2025

2 total trades

Most Recent

Buy DTIL

Dec 17, 2025 · $12.7K

Stanley Frankel's Insider Trading at Precision BioSciences, Inc. (DTIL)

Buys

2 · $26.1K

Sells

0 · $0.00

Total Shares Bought

5,400

Total Shares Sold

DTIL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 17, 2025↗	Buy	2,700	$4.70	$12.7K	19,478
Sep 30, 2025↗	Buy	2,700	$4.97	$13.4K	16,778

Related Insiders

Michael Amoroso

director, officer: President and CEO

DTILSell · Feb 18, 2026

Michael Amoroso

President and CEO

DTILSell · Feb 18, 2026

John Alexander Kelly

Chief Financial Officer

DTILSell · Feb 18, 2026

John Alexander Kelly

officer: Chief Financial Officer

DTILSell · Feb 18, 2026

Dario Scimeca

General Counsel and Secretary

DTILSell · Feb 18, 2026

Dario Scimeca

officer: General Counsel and Secretary

DTILSell · Feb 18, 2026

SMITH J. JEFFERSON

Chief Research Officer

DTILSell · Feb 18, 2026

SMITH J. JEFFERSON

officer: Chief Research Officer

DTILSell · Feb 18, 2026

Explore More Insider Trading Data

DTIL Insider Trading Activity

View all insider trades at Precision BioSciences, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity